NO20041494L - Nye ligander for HisB 10 Zn2+ -setene i insulinheksameren i R-form - Google Patents
Nye ligander for HisB 10 Zn2+ -setene i insulinheksameren i R-formInfo
- Publication number
- NO20041494L NO20041494L NO20041494A NO20041494A NO20041494L NO 20041494 L NO20041494 L NO 20041494L NO 20041494 A NO20041494 A NO 20041494A NO 20041494 A NO20041494 A NO 20041494A NO 20041494 L NO20041494 L NO 20041494L
- Authority
- NO
- Norway
- Prior art keywords
- sites
- insulin
- hisb
- insulin hexamer
- novel ligands
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 12
- 102000004877 Insulin Human genes 0.000 title abstract 6
- 108090001061 Insulin Proteins 0.000 title abstract 6
- 229940125396 insulin Drugs 0.000 title abstract 6
- 239000003446 ligand Substances 0.000 title abstract 3
- 239000012634 fragment Substances 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 125000003636 chemical group Chemical group 0.000 abstract 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200101337 | 2001-09-14 | ||
| US32392501P | 2001-09-21 | 2001-09-21 | |
| DKPA200201066 | 2002-07-05 | ||
| US39605102P | 2002-07-10 | 2002-07-10 | |
| PCT/DK2002/000595 WO2003027081A2 (en) | 2001-09-14 | 2002-09-13 | NOVEL LIGANDS FOR THE HisB10 Zn2+ SITES OF THE R-STATE INSULIN HEXAMER |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041494L true NO20041494L (no) | 2004-04-13 |
Family
ID=27439845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041494A NO20041494L (no) | 2001-09-14 | 2004-04-13 | Nye ligander for HisB 10 Zn2+ -setene i insulinheksameren i R-form |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7879893B2 (no) |
| EP (1) | EP1429763B1 (no) |
| JP (1) | JP4554207B2 (no) |
| CN (1) | CN1558762A (no) |
| AT (1) | ATE363278T1 (no) |
| BR (1) | BR0212522A (no) |
| CA (1) | CA2460541A1 (no) |
| CZ (1) | CZ2004313A3 (no) |
| DE (1) | DE60220424T2 (no) |
| ES (1) | ES2288195T3 (no) |
| HU (1) | HUP0401492A3 (no) |
| MX (1) | MXPA04002404A (no) |
| NO (1) | NO20041494L (no) |
| PL (1) | PL369119A1 (no) |
| WO (1) | WO2003027081A2 (no) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070060606A1 (en) * | 1999-10-07 | 2007-03-15 | Robertson Harold A | Compounds and methods for modulating phosphodiesterase 10A |
| US7087631B2 (en) * | 2002-07-18 | 2006-08-08 | Inotek Pharmaceuticals Corporation | Aryltetrazole compounds, and compositions thereof |
| US7078423B2 (en) * | 2002-07-18 | 2006-07-18 | Inotek Pharmaceuticals Corporation | 5-Aryltetrazole compounds, compositions thereof, and uses therefor |
| US20040063098A1 (en) * | 2002-09-26 | 2004-04-01 | Hargreaves John S. | Methods for producing multilayer ligand arrays |
| US20060276520A1 (en) * | 2002-11-13 | 2006-12-07 | Rigel Pharmaceuticals, Inc. | Rhodanine derivatives and pharmaceutical compositions containing them |
| AU2003291972A1 (en) * | 2002-12-20 | 2004-07-14 | Novo Nordisk A/S | Pharmaceutical compositions comprising insulin and legends of insulin hexamer |
| US20050065066A1 (en) * | 2002-12-20 | 2005-03-24 | Kaarsholm Niels Christian | Stabilised insulin compositions |
| US7521465B2 (en) * | 2003-01-17 | 2009-04-21 | Bexel Pharmaceuticals, Inc. | Diphenyl ether derivatives |
| US7781464B2 (en) | 2003-01-17 | 2010-08-24 | Bexel Pharmaceuticals, Inc. | Heterocyclic diphenyl ethers |
| WO2004080480A1 (en) * | 2003-03-11 | 2004-09-23 | Novo Nordisk A/S | Pharmaceutical preparations comprising acid-stabilised insulin |
| US20060258561A1 (en) * | 2003-03-13 | 2006-11-16 | Novo Nordisk A/S | Novel NPH insulin preparations |
| CA2531170C (en) * | 2003-07-02 | 2011-05-10 | Teva Gyogyszergyar Reszvenytarsasag | Aztreonam l-lysine and methods for the preparation thereof |
| US7087576B2 (en) * | 2003-10-07 | 2006-08-08 | Bexel Pharmaceuticals, Inc. | Dipeptide phenyl ethers |
| US7037927B2 (en) * | 2003-10-16 | 2006-05-02 | Abbott Laboratories | Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| JP5697831B2 (ja) | 2003-12-03 | 2015-04-08 | ノヴォ ノルディスク アー／エス | 単鎖インシュリン |
| EP1757591A4 (en) * | 2004-05-26 | 2010-05-05 | Eisai R&D Man Co Ltd | ZIMTSÄUREAMIDVERBINDUNG |
| WO2006005667A2 (en) | 2004-07-08 | 2006-01-19 | Novo Nordisk A/S | Polypeptide protracting tags comprising a tetrazole moiety |
| WO2006005683A1 (en) * | 2004-07-09 | 2006-01-19 | Novo Nordisk A/S | Phamaceutical preparations comprising insulin |
| JP4787254B2 (ja) * | 2004-08-05 | 2011-10-05 | エフ．ホフマン−ラ ロシュ アーゲー | インドール、インダゾールまたはインドリン誘導体 |
| JP2008513384A (ja) * | 2004-09-17 | 2008-05-01 | ノボ ノルディスク アクティーゼルスカブ | インスリンおよびインスリン分泌性ペプチドを含有する医薬組成物 |
| WO2006035954A1 (en) * | 2004-09-28 | 2006-04-06 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril compound |
| KR20070083781A (ko) | 2004-10-26 | 2007-08-24 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 신나미드 화합물의 비정질체 |
| TWI370130B (en) | 2005-11-24 | 2012-08-11 | Eisai R&D Man Co Ltd | Two cyclic cinnamide compound |
| TWI378091B (en) | 2006-03-09 | 2012-12-01 | Eisai R&D Man Co Ltd | Multi-cyclic cinnamide derivatives |
| TW200800978A (en) * | 2006-03-23 | 2008-01-01 | Otsuka Pharma Co Ltd | Carbazole compound |
| JP5191155B2 (ja) * | 2006-03-27 | 2013-04-24 | 大塚製薬株式会社 | カルボスチリル化合物からなる医薬 |
| CL2008000582A1 (es) | 2007-02-28 | 2008-06-27 | Eisai R&D Man Co Ltd | Compuestos ciclicos derivados de oximorfolina condensados; farmacos que comprenden a dichos compuestos; y su uso para tratar enfermedad de alzheimer, demencia senil, sindrome de down o amiloidosis. |
| US7935815B2 (en) | 2007-08-31 | 2011-05-03 | Eisai R&D Management Co., Ltd. | Imidazoyl pyridine compounds and salts thereof |
| AR068121A1 (es) | 2007-08-31 | 2009-11-04 | Eisai R&D Man Co Ltd | Compuestos multiciclicos para tratar enfermedades neurodegenerativas |
| CN104125948A (zh) | 2012-02-21 | 2014-10-29 | 拜耳知识产权有限责任公司 | 具有除草活性的4-硝基-取代的n-(四唑-5-基)芳基羧酸酰胺、n-(三唑-5-基)芳基羧酸酰胺以及n-(1,3,4-噁二唑-2-基)芳基羧酸酰胺 |
| US9447069B2 (en) * | 2012-04-30 | 2016-09-20 | Innov17 Llc | ROR modulators and their uses |
| KR101942752B1 (ko) * | 2012-11-05 | 2019-01-28 | 주식회사 엘지화학 | Ｇｐｒ120 효능제로서의 티오아릴 유도체 |
| JP6156845B2 (ja) * | 2014-03-04 | 2017-07-05 | 株式会社島津製作所 | マトリックス支援レーザ脱離イオン化質量分析用マトリックス |
| AU2015360416A1 (en) * | 2014-12-10 | 2017-06-08 | Massachusetts Institute Of Technology | Fused 1,3-azole derivatives useful for the treatment of proliferative diseases |
| TW201632516A (zh) | 2014-12-11 | 2016-09-16 | 哈佛大學校長及研究員協會 | 細胞壞死抑制劑與相關方法 |
| WO2016154255A1 (en) * | 2015-03-23 | 2016-09-29 | University Of Miami | Inhibitors of the notch transcriptional activation complex and methods for use of the same |
| US10106555B2 (en) | 2016-02-16 | 2018-10-23 | Massachusetts Institute Of Technology | Max binders as MYC modulators and uses thereof |
| WO2018005660A1 (en) * | 2016-06-28 | 2018-01-04 | University Of Kentucky Research Foundation | Prostaglandin e synthase inhibitors and methods for utilizing the same |
| EP3558992A4 (en) | 2016-12-15 | 2020-12-02 | ONO Pharmaceutical Co., Ltd. | TREK CHANNEL ACTIVATOR (K + CHANNELS ASSOCIATED WITH TWIK) |
| US12473312B2 (en) | 2018-03-16 | 2025-11-18 | The Board Of Regents Of The University Of Oklahoma | Agonists of peroxisome proliferator-activated receptor alpha (PPAR+60 ) and methods of use |
| US11447452B2 (en) * | 2018-03-16 | 2022-09-20 | The Board Of Regents Of The University Of Oklahoma | Agonists of peroxisome proliferator-activated receptor alpha and methods of use |
| ES3042549T3 (en) | 2019-04-11 | 2025-11-21 | Univ Miami | Improved inhibitors of the notch transcriptional activation complex and methods for use of the same |
| WO2024226603A1 (en) * | 2023-04-24 | 2024-10-31 | Regents Of The University Of Minnesota | Therapeutic compounds |
| CN121135615A (zh) * | 2025-11-18 | 2025-12-16 | 湖南初源新材料股份有限公司 | 一种用于感光树脂组合物的蒽甲硫代水杨酸及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DOP1982004086A (es) * | 1981-08-27 | 1988-03-22 | Lilly Co Eli | Formula farmaceutica que comprende insulina humana y proinsulina humana |
| US5646120A (en) * | 1990-10-24 | 1997-07-08 | Allelix Biopharmaceuticals, Inc. | Peptide-based inhibitors of HIV replication |
| US5830999A (en) | 1995-01-26 | 1998-11-03 | Regents Of The University Of California | Stabilization of insulin through ligand binding interations |
| WO2000029013A1 (en) * | 1998-11-18 | 2000-05-25 | Novo Nordisk A/S | Stable aqueous insulin preparations without phenol and cresol |
-
2002
- 2002-09-13 ES ES02774468T patent/ES2288195T3/es not_active Expired - Lifetime
- 2002-09-13 WO PCT/DK2002/000595 patent/WO2003027081A2/en not_active Ceased
- 2002-09-13 CA CA002460541A patent/CA2460541A1/en not_active Abandoned
- 2002-09-13 US US10/332,541 patent/US7879893B2/en not_active Expired - Fee Related
- 2002-09-13 HU HU0401492A patent/HUP0401492A3/hu unknown
- 2002-09-13 DE DE60220424T patent/DE60220424T2/de not_active Expired - Lifetime
- 2002-09-13 PL PL02369119A patent/PL369119A1/xx not_active Application Discontinuation
- 2002-09-13 CZ CZ2004313A patent/CZ2004313A3/cs unknown
- 2002-09-13 BR BR0212522-6A patent/BR0212522A/pt not_active IP Right Cessation
- 2002-09-13 AT AT02774468T patent/ATE363278T1/de not_active IP Right Cessation
- 2002-09-13 JP JP2003530671A patent/JP4554207B2/ja not_active Expired - Fee Related
- 2002-09-13 EP EP02774468A patent/EP1429763B1/en not_active Expired - Lifetime
- 2002-09-13 CN CNA028203402A patent/CN1558762A/zh active Pending
- 2002-09-13 MX MXPA04002404A patent/MXPA04002404A/es not_active Application Discontinuation
-
2004
- 2004-04-13 NO NO20041494A patent/NO20041494L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20030229120A1 (en) | 2003-12-11 |
| BR0212522A (pt) | 2004-08-10 |
| CZ2004313A3 (cs) | 2004-07-14 |
| ATE363278T1 (de) | 2007-06-15 |
| CN1558762A (zh) | 2004-12-29 |
| US7879893B2 (en) | 2011-02-01 |
| CA2460541A1 (en) | 2003-04-03 |
| HUP0401492A3 (en) | 2008-05-28 |
| ES2288195T3 (es) | 2008-01-01 |
| DE60220424D1 (de) | 2007-07-12 |
| EP1429763B1 (en) | 2007-05-30 |
| MXPA04002404A (es) | 2004-05-31 |
| JP2005508335A (ja) | 2005-03-31 |
| HUP0401492A2 (hu) | 2004-11-29 |
| PL369119A1 (en) | 2005-04-18 |
| JP4554207B2 (ja) | 2010-09-29 |
| EP1429763A2 (en) | 2004-06-23 |
| DE60220424T2 (de) | 2008-03-06 |
| WO2003027081A3 (en) | 2004-03-25 |
| WO2003027081A2 (en) | 2003-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041494L (no) | Nye ligander for HisB 10 Zn2+ -setene i insulinheksameren i R-form | |
| DE60237828D1 (de) | Neue verbindungen | |
| PT1086124E (pt) | Ciclosporinas novas | |
| UA84432C2 (ru) | Очищенные пептиды и соединения, которые их содержат | |
| GB2431404A (en) | Peptide | |
| BR0210078A (pt) | Composto, uso do mesmo, e, formulação farmacêutica | |
| ATE481987T1 (de) | Verfahren zur radiofluoridierung von biologisch aktiven vektoren | |
| GB0004128D0 (en) | Novel compounds | |
| DE69326250D1 (de) | Neuropeptide y antagoniste | |
| FI924503A0 (fi) | Foerbaettrade trombininhibitorer | |
| DE69837324D1 (de) | Behandlung der multiplen sklerose durch einnahme von copolymer-1 | |
| SE0101038D0 (sv) | Novel compounds | |
| BR0312889A (pt) | Polipeptìdeo t20 peguilado | |
| FR2818906B1 (fr) | Association medicamenteuse d'une biguanine et d'un transporteur, par exemple de metformine et d'arginine | |
| DK1446425T3 (da) | Behandling af infektioner forårsaget af mikroorganismer | |
| AU2003291972A8 (en) | Pharmaceutical compositions comprising insulin and legends of insulin hexamer | |
| WO2001052900A3 (en) | Novel orthogonally protected amino acid chelators for biomedical applications | |
| ATE242202T1 (de) | Peptide | |
| EA200200807A1 (ru) | Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece | |
| DK1127064T3 (da) | Hidtil ukendte aminosyresekvenser, DNA, der koder for aminosyresekvenserme, antistoffer, der er rettet mod sådanne sekvenser, og forskellige anvendelser deraf | |
| DK1180094T3 (da) | Kondenserede polycykliske aminosyrer som farmaceutiske midler | |
| IL159493A0 (en) | Pharmaceutical formulation containing an ltb4 antagonist | |
| WO2003048187A3 (en) | Peptides and use thereof in therapeutic agents against hiv infection | |
| WO2003089472A3 (en) | Anti-nls scfv and peptides and uses thereof in nuclear import inhibition | |
| WO2003029290A1 (en) | Drug transporter and use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |